HIV :: Researchers discover new details about HIV-1 entry and infection

The primary targets of HIV-1 infection in the human vagina have been definitively identified in a new study published in the February 2007 issue of the journal Immunity, published by Cell Press. The findings are likely to guide development of new strategies that will prevent HIV-1 transmission.

Cancer :: Arizona State University and Mayo Clinic join forces to develop cancer vaccine

Two major research organizations in the Phoenix area have announced they will collaborate on an ambitious goal: Creating a vaccine to prevent the development of cancer. Researchers at the Biodesign Institute at Arizona State University (ASU) in Tempe and Mayo Clinic will use the latest developments in laboratory and clinical sciences to reach their goal — finding components in cancer that could be used to vaccinate against the occurrence of the disease.

HIV :: Scientists unveil piece of HIV protein that may be key to AIDS vaccine development

In a finding that could have profound implications for AIDS vaccine design, researchers led by a team at the NIAID have generated an atomic-level picture of a key portion of an HIV surface protein as it looks when bound to an infection-fighting antibody. Unlike much of the constantly mutating virus, this protein component is stable and — more importantly, say the researchers — appears vulnerable to attack from this specific antibody, known as b12, that can broadly neutralize HIV.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack